NASDAQ:CTRE - CareTrust REIT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $23.11
  • Forecasted Upside: 3.22 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 1 Strong Buy Ratings
$22.39
▼ -0.05 (-0.22%)
1 month | 3 months | 12 months
Get New CareTrust REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTRE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$23.11
▲ +3.22% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for CareTrust REIT in the last 3 months. The average price target is $23.11, with a high forecast of $26.00 and a low forecast of $21.00. The average price target represents a 3.22% upside from the last price of $22.39.
Buy
The current consensus among 9 contributing investment analysts is to buy stock in CareTrust REIT. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 1 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2019
  • 1 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2019
  • 1 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/25/2020
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2020
  • 1 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2020
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/20/2020
  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/19/2021

Latest Recommendations

  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2021BarclaysBoost Price TargetOverweight$21.00 ➝ $25.00Low
i
1/13/2021MizuhoBoost Price TargetNeutral$19.00 ➝ $22.00Low
i
1/7/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$25.00 ➝ $26.00Medium
i
12/14/2020KeyCorpUpgradeSector Weight ➝ Overweight$24.00Low
i
12/2/2020Berenberg BankUpgradeHold ➝ BuyLow
i
11/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$20.00 ➝ $22.00Low
i
10/2/2020MizuhoBoost Price TargetNeutral$13.00 ➝ $19.00High
i
9/1/2020Stifel NicolausReiterated RatingBuy$22.00High
i
8/10/2020Raymond JamesBoost Price TargetStrong-Buy$21.00 ➝ $22.00Medium
i
8/3/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$20.00 ➝ $21.00High
i
6/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$20.00 ➝ $21.00Low
i
4/29/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$19.00High
i
4/6/2020MizuhoUpgradeUnderperform ➝ Neutral$19.00 ➝ $13.00High
i
3/26/2020Wells Fargo & CompanyLower Price TargetOverweight$24.00 ➝ $20.00Low
i
2/28/2020Berenberg BankDowngradeBuy ➝ Hold$24.00Low
i
Rating by Connor Siversky at Berenberg Bank
1/7/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$26.00 ➝ $22.00Medium
i
12/19/2019MizuhoInitiated CoverageUnderperformMedium
i
9/12/2019Berenberg BankInitiated CoverageBuy$29.00Medium
i
9/3/2019BarclaysInitiated CoverageOverweight$26.00Low
i
8/21/2019Capital One FinancialUpgradeEqual Weight ➝ Overweight$25.00Low
i
Rating by D. Bernstein at Capital One Financial Co.
8/7/2019BMO Capital MarketsReiterated RatingBuy$26.00High
i
5/31/2019Raymond JamesDowngradeStrong-Buy ➝ Market Perform$25.00Medium
i
5/8/2019Stifel NicolausSet Price TargetBuy$26.00Low
i
Rating by Chad Vanacore at Stifel Nicolaus
4/9/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$22.00 ➝ $25.00Medium
i
2/14/2019BMO Capital MarketsReiterated RatingBuy$22.00High
i
1/9/2019BMO Capital MarketsUpgradeMarket Perform ➝ OutperformHigh
i
1/8/2019Raymond JamesUpgradeOutperform ➝ Strong-BuyHigh
i
12/4/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$18.50 ➝ $22.00High
i
11/28/2018Stifel NicolausUpgradeHold ➝ Buy$17.00 ➝ $21.00High
i
11/5/2018Cantor FitzgeraldReiterated RatingBuy$20.00High
i
10/29/2018Cantor FitzgeraldReiterated RatingBuy$20.00Medium
i
8/21/2018KeyCorpBoost Price TargetOverweight ➝ Buy$16.00 ➝ $20.00Low
i
Rating by Jordan Sadler at KeyCorp
8/9/2018Royal Bank of CanadaReiterated RatingSector Perform ➝ Hold$16.00 ➝ $18.00High
i
Rating by Michael Carroll at Royal Bank of Canada
5/31/2018Wells Fargo & CompanySet Price TargetOutperform ➝ Buy$16.50 ➝ $19.00Low
i
Rating by Todd Stender at Wells Fargo & Company
5/24/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Hold$15.00 ➝ $16.00Low
i
Rating by Michael Carroll at Royal Bank of Canada
5/8/2018Cantor FitzgeraldInitiated CoverageBuy$16.00High
i
Rating by J. France at Cantor Fitzgerald
5/8/2018BMO Capital MarketsReiterated RatingHold$15.00High
i
Rating by John Kim at BMO Capital Markets
3/27/2018BMO Capital MarketsReiterated RatingHold$15.00Low
i
3/6/2018Royal Bank of CanadaReiterated RatingHold$15.00Medium
i
3/6/2018KeyCorpSet Price TargetOverweight ➝ Buy$20.00 ➝ $16.00Low
i
Rating by Jordan Sadler at KeyCorp
3/5/2018Cantor FitzgeraldInitiated CoverageOverweight$16.00Low
i
Rating by J. France at Cantor Fitzgerald
2/28/2018Stifel NicolausSet Price TargetHold ➝ Hold$19.00 ➝ $17.00High
i
1/12/2018StephensSet Price TargetBuy$19.00Low
i
Rating by Dana Hambly at Stephens
12/19/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$20.00Medium
i
Rating by Todd Stender at Wells Fargo & Company
11/9/2017BMO Capital MarketsReiterated RatingHold$20.00N/A
i
Rating by John Kim at BMO Capital Markets
11/9/2017Stifel NicolausReiterated RatingHold ➝ Hold$17.00 ➝ $19.00N/A
i
10/29/2017KeyCorpSet Price TargetBuy$20.00N/A
i
10/23/2017Capital One FinancialInitiated CoverageEqual Weight$21.00N/A
i
10/22/2017Capital One FinancialReiterated RatingEqual Weight$21.00N/A
i
Rating by D. Bernstein at Capital One Financial Co.
8/25/2017KeyCorpReiterated RatingBuy$20.00Low
i
6/20/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$18.00 ➝ $20.00Low
i
Rating by John Kim at BMO Capital Markets
5/17/2017Raymond JamesReiterated RatingOutperform$17.00 ➝ $19.00Low
i
5/15/2017BMO Capital MarketsSet Price TargetBuy$18.00Low
i
Rating by John Kim at BMO Capital Markets
5/3/2017Canaccord GenuityReiterated RatingBuy$19.00Low
i
4/12/2017BMO Capital MarketsReiterated RatingBuy$18.00Low
i
3/30/2017Canaccord GenuityBoost Price TargetBuy ➝ Buy$18.00 ➝ $19.00High
i
3/20/2017BMO Capital MarketsReiterated RatingBuy$16.00Low
i
2/8/2017Canaccord GenuityReiterated RatingBuy$18.00N/A
i
1/3/2017Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$16.00N/A
i
11/22/2016JMP SecuritiesReiterated RatingHoldN/A
i
Rating by Peter Martin at JMP Securities
11/3/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Paul Morgan at Canaccord Genuity
11/3/2016BarclaysReiterated RatingHold$16.00N/A
i
10/24/2016JMP SecuritiesInitiated CoverageMarket PerformN/A
i
9/14/2016StephensInitiated CoverageOverweight$16.00N/A
i
9/8/2016Canaccord GenuityReiterated RatingBuy$18.00N/A
i
Rating by Paul Morgan at Canaccord Genuity
8/25/2016Raymond JamesInitiated CoverageOutperform$13.50N/A
i
Rating by Jonathan Hughes at Raymond James
8/22/2016BarclaysInitiated CoverageEqual Weight$16.00N/A
i
8/15/2016Canaccord GenuityReiterated RatingBuy$16.00 ➝ $18.00N/A
i
8/15/2016Canaccord GenuityBoost Price TargetBuy$16.00 ➝ $18.00N/A
i
Rating by Paul Morgan at Canaccord Genuity
7/26/2016Wells Fargo & CompanyReiterated RatingMarket PerformN/A
i
7/26/2016Wells Fargo & CompanyInitiated CoverageMarket PerformN/A
i
5/12/2016Canaccord GenuityReiterated RatingBuy$16.00N/A
i
Rating by Paul Morgan at Canaccord Genuity
4/12/2016Raymond JamesReiterated RatingOutperform$13.00 ➝ $14.00N/A
i
4/1/2016BMO Capital MarketsReiterated RatingOutperform$12.50 ➝ $14.00N/A
i
3/30/2016BMO Capital MarketsBoost Price TargetOutperform$12.50 ➝ $14.00N/A
i
3/23/2016Canaccord GenuityReiterated RatingBuy$15.00N/A
i
Rating by Paul Morgan at Canaccord Genuity
2/12/2016Canaccord GenuityReiterated RatingBuy$15.00N/A
i
Rating by Paul Morgan at Canaccord Genuity
(Data available from 1/20/2016 forward)
CareTrust REIT logo
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.
Read More

Today's Range

Now: $22.39
$22.04
$22.75

50 Day Range

MA: $22.11
$20.28
$23.49

52 Week Range

Now: $22.39
$7.16
$23.83

Volume

508,420 shs

Average Volume

712,548 shs

Market Capitalization

$2.14 billion

P/E Ratio

26.34

Dividend Yield

4.46%

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of CareTrust REIT?

The following Wall Street research analysts have issued research reports on CareTrust REIT in the last twelve months: Barclays PLC, Berenberg Bank, BMO Capital Markets, KeyCorp, Mizuho, Raymond James, Royal Bank of Canada, Stifel Nicolaus, TheStreet, Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for CareTrust REIT?

9 Wall Street analysts have set twelve-month price targets for CareTrust REIT in the last year. Their average twelve-month price target is $23.11, suggesting a possible upside of 3.2%. BMO Capital Markets has the highest price target set, predicting CTRE will reach $26.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $21.00 for CareTrust REIT in the next year.

What is the current consensus analyst rating for CareTrust REIT?

CareTrust REIT currently has 1 hold rating, 7 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CTRE will outperform the market and that investors should add to their positions of CareTrust REIT.

What other companies compete with CareTrust REIT?

How do I contact CareTrust REIT's investor relations team?

CareTrust REIT's physical mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust's listed phone number is 949-542-3130 and its investor relations email address is ir@caretrustreit.com. The official website for CareTrust REIT is www.caretrustreit.com.